Category: Celgene Get Speedy OK For Blood Cancer Drug

With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug

  1. With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug  Xconomy
  2. Cambridge biotech Agios wins approval for its leukemia drug  The Boston Globe
  3. FDA OKs Celgene’s enasidenib for certain type of acute myeloid leukemia  Seeking Alpha
  4. Full coverage

from Business – Google News http://www.xconomy.com/boston/2017/08/01/with-fda-nod-agios-celgene-get-speedy-ok-for-blood-cancer-drug/

Advertisements

With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug

  1. With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug  Xconomy
  2. Cambridge biotech Agios wins approval for its leukemia drug  The Boston Globe
  3. FDA OKs Celgene’s enasidenib for certain type of acute myeloid leukemia  Seeking Alpha
  4. Full coverage

from Business – Google News http://www.xconomy.com/boston/2017/08/01/with-fda-nod-agios-celgene-get-speedy-ok-for-blood-cancer-drug/